Results - Announcements
Aurobindo Pharma Ltd share price gained 0.12% to Rs 1701.1 after the company's net profit inched up 8.90% to Rs 1123.84 crore, while revenue from operations increased 12.32% to Rs 10227.28 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, gaining 5.14%. It has marginally improved by 2.03% over last one week and crept higher by 1.77% in last one month while the market capitalization of Aurobindo Pharma Ltd has improved by 2.79% and 2.41% in the same period respectively.
Profit before tax (PBT) of Aurobindo Pharma Ltd stood at Rs 1687.67 crore in Q3 FY26, jumping 32.27% year-on-year, and heading higher 11.39% quarter-on-quarter. EBITDA came in at Rs 1988 crore, expanding by 27.61% YoY and rallying 22.93% sequentially.
Total expenses went up by 11.38% to Rs 8638.69 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 2980.28 crore, inching up 2.97% YoY, while employee benefits expense was at Rs 1658.55 crore, soaring 12.05% YoY.
For the TTM ended FY26, revenue from operations posted a slight growth of 6.39% to Rs 33384.74 crore, while net profit saw a marginal increase of 0.56% to Rs 3502.97 crore, compared to previous TTM. EBITDA surged by 608871% to Rs 6353.64 crore, and PBT saw a minor gain of 0.90% to Rs 5111.85 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 5526.37 crore in FY26, as against Rs 3924.62 crore in FY25.
Aurobindo Pharma Ltd rallied 47.79% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 7.38% during the same period.